RE: Raising to push ahead with development8 Dec 2025 11:33
For all the moaning about fundraising and dilution, it’s worth stepping back and looking at the bigger picture. Once ICC2 was lost, it was obvious the company would need to raise capital. Six months ago, Zenith’s entire valuation was tied almost exclusively to the arbitration cases. If they won, the upside was transformative; if they lost, there was nothing else in the portfolio to fall back on. That was always the binary risk.
So complaining about dilution in relation to the arbitration outcome doesn’t really make sense. If Zenith wins $573 million in the ICSID case, that alone adds around 66p per share to the company’s value based on today’s share count. That’s roughly a 20× rerate overnight.
Yes—had we still been at the 400 million shares in issue at the start of the year, that same result would have equated to about £1.07 per share, a 32× rerate rather than 20×. But given the unexpected loss of ICC2, is that difference really catastrophic? The value creation would still be enormous.
More importantly, the company is no longer a one-bet story. The solar assets are nearing the point where they can generate real near-term value, and the newly acquired uranium portfolio—6,000 tonnes of uranium oxide—carries huge long-term potential. At today’s prices, that uranium alone represents well over $1 billion in the ground.
It seems clear management originally believed all arbitration cases were robust, but ICC2 was a wake-up call on how unpredictable legal systems can be. That’s precisely why they’ve diversified into solar and uranium: to ensure Zenith’s future isn’t entirely dependent on a single verdict. Yes, it required some capital and therefore dilution, but the trade-off is that Zenith now has three significant potential value drivers, not just one.
The company is in a stronger strategic position today than it was at the start of the year. Investors should at least acknowledge that this evolution reduces risk rather than increases it.